Want to join the conversation?
$REGN and $TEVA announced global agreement to develop and commercialize fasinumab, investigational NGF antibody in Phase 3 clinical development for osteoarthritis pain and in Phase 2 development for chronic low back pain. $TEVA will pay $REGN $250MM upfront and share equally in global commercial value as well as ongoing R&D costs of about $1Bil.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.